PUBLICATIONS

  1. Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)) : A population based study. British Journal of Obstetrics & Gynaecology. Jul 5, 2017.
  2. Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma. International Journal of Gynecological Cancer. Apr 8, 2017.
  3. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial. Journal American Medical Association. Mar 28;317(12) : 1224-1233, 2017.
  4. Value of Specialist Pathology Review in a Single Statewide Gynecologic Cancer Service. International Journal of Gynecological Cancer. Jan;27(1) : 171-176, 2017.
  5. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins. Acta Obstetricia Et Gynecologica Scandinavica: 51: 52 February 2017. 
  6. Value of Specialist Pathology Review in a Single Statewide Gynecologic Cancer Service. International Journal of Gynecological Cancer 27(1) : 171-176 : 51: 52 December 2016. 
  7. Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma-in-situ. American Journal of Obstetrics and Gynecology. 60: 61 November 2016. 
  8. Sexuality and quality of life in women with a prior diagnosis of breast cancer after risk-reducing salpingo-oophorectomy. Breast. Dec;30:26-31, 2016. 
  9. Discussing Sexuality With Women Considering Risk-Reducing Salpingo-oophorectomy: An International Survey of Current Practice in Gynecologic Oncology. International Journal of Gynecological Cancer: 58 : 59 July, 2016.
  10. Factors Influencing Participation in Health Behaviors in Endometrial Cancer Survivors : Motivation and Health Behaviors in Endometrial Cancer Survivors. Psycho-Oncology : 60-61 January 2016.
  11. Outcomes of Total Laparoscopic Hysterectomy Using a 5 mm vs. 10 mm Laparoscope. Obstetrical and Gynecological Survey. 71(1) :17-18 · January 2016
  12. The Effects of Pre-Operative Menopausal Status and Hormone Replacement Therapy (HRT) on Sexuality and Quality of Life After Risk-Reducing Salpingo-Oophorectomy. Maturitas. Mar;85:42-8, 2016.
  13. Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy. Gynecologic Oncology, November 2016.
  14. Outcomes of total laparoscopic hysterectomy using a 5mm vs. 10mm laparoscope: A randomized control trial. Journal of Minimally Invasive Gynaecology. 23(1) : 101-106, 2016.
  15. Morcellation of occult uterine malignancies : An Australian single institution retrospective study. Australian New Zealand Journal Obstetrics & Gynaecology. August, 2015.
  16. The positive impact of structured teaching in the operating room. Australian New Zealand Journal Obstetrics & Gynaecology. 55(6) August, 2015.
  17. Ovarian Sex Cord-Stromal Tumors in Patients With Probable or Confirmed Germline DICER1 Mutations. International Journal Gynecologic Pathology. 34(3) : 266-274 · May, 2015.
  18. Effect of Umbilical Port and Endoscope Size on Discharge Times and postoperative Recovery after total laparoscopic hysterectomy: A retrospective review. Journal Gynaecologic Surgery, October 30(5) : 273-275, 2014.
  19. Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer – a population based study. Gynecologic Oncology, May ; 129(2) : 310-7, 2013.
  20. The Evolving Role of a Gynaecologic Oncologist in a Tertiary Hospital. Australian New Zealand Journal Obstetrics & Gynaecology. Feb ; 54(1) : 26-9, 2014.
  21. Appendiceal hamartoma resembling PHTS of soft tissue in a patient with Cowden syndrome. Journal Clinical Pathology. Jan ; 67(1) : 81-3, 2014.
  22. The introduction and the validation of a surgical encounter template to facilitate surgical coaching of gynaecologists at a metropolitan tertiary obstetrics and gynaecology hospital. Australian New Zealand Journal Obstetrics & Gynaecology. Oct; 53(5) : 477-83, 2013.
  23. Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis. Pathology. Jun; 45(4) : 382-7, 2013.
  24. Mullerian carcinosarcoma arising in the cecum associated with florid vascular proliferation/glomeruloid microvascular proliferation. International Journal Gynecologic Pathology. Jan; 32(1) : 38-43, 2013.
  25. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: results from a randomised controlled trial. European Journal Cancer. Sep;48(14):2155-62, 2012.
  26. The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer. International Journal Cancer. Aug 15; 131(4) : 885-90, 2012.
  27. Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: results from a randomised controlled trial. European Journal Cancer. May;48(8):1147-53, 2012.
  28. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial. Lancet Oncology. Aug;11(8):772-80, 2010.
  29. Management of trauma during pregnancy. Australian New Zealand Journal of Surgery. Mar;74(3):125-8. 2004.
  30. Cancer Council Australian/Australian Government Guidelines Management of apparent early stage low and high risk endometrial cancer What is the role of preoperative imaging for low and high-risk apparent early stage endometrial cancer? Hammond I, Salfinger S, Dillon E (http://wiki.cancer.org.au/australia/Guidelines:Endometrial_cancer/Treatment/Early_stage)
  31. Australian Gynaecologic Endoscopy Society - AGES Training Program in Gynaecological Endoscopy - Curriculum co-author